Skip to main content
. 2017 May 7;8(30):49380–49394. doi: 10.18632/oncotarget.17673

Figure 2. Expressions of ERS-related proteins and PI3K/AKT/mTOR pathway-related proteins after SKOV3 cells were treated by different concentrations of tunicamycin (0, 0.5, 1, 1.5 mg/L) for 24 h.

Figure 2

(A) Expressions of CHOP, PERK, PDI and Grp78 proteins. (B) the expressions of PI3K, AKT, mTOR, p-PI3K, p-AKT and p-mTOR. *P < 0.05 compared with the 0 mg/L group; the experiments were performed three times and the average values were obtained.